Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXU4RX
|
||||
| Drug Name |
2,2-dimethyl-3-phenylpropyl(S)-1,2-dioxo-1-((R)-1-phenylethylamino)heptan-3-ylcarbamate
|
||||
| Synonyms |
CHEMBL182775
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C27H36N2O4
|
||||
| Canonical SMILES |
CCCC[C@H](NC(=O)OCC(C)(C)Cc1ccccc1)C(=O)C(=O)N[C@H](C)c2ccccc2
|
||||
| InChI |
InChI=1S/C27H36N2O4/c1-5-6-17-23(24(30)25(31)28-20(2)22-15-11-8-12-16-22)29-26(32)33-19-27(3,4)18-21-13-9-7-10-14-21/h7-16,20,23H,5-6,17-19H2,1-4H3,(H,28,31)(H,29,32)/t20-,23+/m1/s1
|
||||
| InChIKey |
NMXQSPUYSZKXOQ-OFNKIYASSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Cathepsin K | Target Info | [1587926] | ||
| Cathepsin L | Target Info | [1587926] | |||
| Reactome | Collagen degradation | ||||
| Degradation of the extracellular matrix | |||||
| Activation of Matrix Metalloproteinases | |||||
| Trafficking and processing of endosomal TLR | |||||
| MHC class II antigen presentationR-HSA-1236977:Endosomal/Vacuolar pathway | |||||
| Assembly of collagen fibrils and other multimeric structures | |||||
| MHC class II antigen presentation | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.